Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
WntResearch AB WNT Sweden — 522
CanBas Co.,Ltd. 4575 Japan — 521
CLARITY PHARMACEUTICALS LTD CU6 Australia — 520
Cellid Co., Ltd. 299660 South Korea — 514
NYRADA INC. NYR Australia — 514
KAINOS MEDICINE, INC. 284620 South Korea — 509
Neovacs ALNEV France — 508
NovMetaPharma Co., Ltd. 229500 South Korea — 507
RADIOPHARM THERANOSTICS LIMITED RAD Australia — 504
Peptron, Inc. 087010 South Korea — 503
INVENTISBIO CO., LIMITED. 688382 China — 497
ABL Bio Inc. 298380 South Korea — 493
Pharmadrug Inc. PHRX Canada — 481
Arch Biopartners Inc. ARCH Canada — 472
Genor Biopharma Holdings Limited 6998 Cayman Islands — 471
Abbisko Cayman Limited 2256 Cayman Islands — 469
MediciNova,Inc. 4875 Japan — 468
CRISM Therapeutics Corporation CRTX Virgin Islands (British) — 464
HBM Holdings Limited 2142 Cayman Islands — 464
CORESTEMCHEMON Inc. 166480 South Korea — 459
InnoCan Pharma Corporation INNO Canada — 452
Kolon TissueGene, Inc. 950160 South Korea — 449
PreveCeutical Medical PREV Canada — 446
CHOSA Oncology AB CHOSA Sweden — 445
BioNxt Solutions Inc. BNXT Canada — 444
BrightPath Biotherapeutics Co., Ltd. 4594 Japan — 439
HINOVA PHARMACEUTICALS INC. 688302 China — 438
Sirnaomics Ltd. 2257 Cayman Islands — 437
BioVaxys Technology Corp. BIOV Canada — 430
GI Innovation Inc. 358570 South Korea — 430
ISLAND PHARMACEUTICALS LIMITED ILA Australia — 430
NurExone Biologic Inc NRX Canada — 430
Aptose Biosciences Inc. APS Canada — 429
Mountain Valley MD Holdings Inc. MVMD Canada — 429
Revive Therapeutics Ltd. RVV Canada — 429
Sona Nanotech Inc. SONA Canada — 429
Lobe Sciences Ltd. LOBE Canada — 425
SunBio, Inc. 067370 South Korea — 421
AbClon Inc. 174900 South Korea — 420
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD NSB Australia — 420
Psyence Group Inc. PSYG Canada — 418
WPD Pharmaceuticals Inc. WBIO Canada — 418
Hamlet BioPharma AB HAMLET Sweden — 409
Philogen PHIL Italy — 408
TiumBio Co., Ltd. 321550 South Korea — 399
SHOUYAO HOLDINGS CO.,LTD 688197 China — 396
Satellos Bioscience Inc. MSCL Canada — 394
EGF Theramed Health Corp. TMED Canada — 391
Appili Therapeutics Inc. APLI Canada — 388
Entheon Biomedical Corp. ENBI Canada — 380

Companies in Biotechnology → Open in the screener →

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard